With caloric intake reduced 30-50% and the body adapting to powerful medications, recovery capacity decreases
Without enough protein, the body breaks down muscle alongside fat lowering metabolic rate and making long-term weight management harder
Nevertheless, SAS is significantly less potent in triggering ferroptosis compared to erastin
The initial muscle loss seen with GLP-1 RA treatment as well as the ongoing replacement of muscle with fat with treatment cycles involving treatment interruptions can result in unfavorable changes in body composition in patients with obesity that can have profoundly negative repercussions, and can exacerbate obesity-related metabolic and health concerns 14,15,16
Synthesis 1-(4-(2,2-Dicyanovinyl)phenyl)-1,2,2-triphenylethene (TPE-DCV) TPE-CHO was prepared according to the previous publication 59